Effect of antibiotic-impregnated catheters on the incidence of infection after cerebrospinal fluid shunting;Efecto de los catéteres impregnados con antibiótico en la incidencia de infección tras procedimientos de derivación de líquido cefalorraquídeo

Medicina Clinica

Volumn 131, Issue 4, 2008, Pages 121-124

  Gutiérrez González, Raquel ^a   Boto, Gregorio R ^a   González, Nieves ^a   Viudez, Isabel ^a   Pérez Zamarrón, Álvaro ^a   Rivero Garvía, Mónica ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Antibiotic impregnated; Catheter; Cerebrospinal fluid shunt; Infection

Indexed keywords

CLINDAMYCIN; RIFAMPICIN;

ARTICLE; CATHETER INFECTION; CATHETERIZATION; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; HUMAN; INCIDENCE; INFECTION RATE; STAPHYLOCOCCUS;

EID: 47049088393     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13124097     Document Type: Article

References (25)

1. Kestle JR, Garton HJ, Whitehead WE, Drake JM, Kulkarni AV, Cochrane DD, et al. Management of shunt infections: a multicenter pilot study. J Neurosurg. 2006;105 3 Suppl:177-81.
2. Lyke KE, Obasanjo OO, Williams MA, O'Brien M, Chotani R, Perl TM. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis. 2001;33:2028-33.
3. Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis. 1975;131:543-52.
4. Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML. Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst. 2005;21:56-61.
5. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien). 1995;136:1-7.
6. Govender ST, Nathoo N, Van Deller JR. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg. 2003;99:831-9.
7. Holloway KL, Barnes T, Choi S, Bullock R, Marshall LF, Eisenberg HM, et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg. 1996;85:419-24.
8. Kan P, Kestle J. Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infection in children. Childs Nerv Syst. 2007;23:773-7.
9. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg. 2001;94:195-201.
10. Lo CH, Spelman D, Bailey M, Cooper J, Rosenfeld JV, Brecknell JE. External ventricular drain infections are independent of drain duration: an argument against elective revision. J Neurosurg. 2007;106:378-83.
11. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy- related infections: a critical review of the literature. Neurosurgery. 2002;51:170-81.
12. Mayhall CG, Archer NH, Lamb VA, Spadora AC, Baggett JW, Ward JD, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med. 1984;310:553-9.
13. Pattavilakom A, Xenos C, Bradfield O, Danks RA. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci. 2007;14:526-31.
14. Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts. Cochrane Database of Syst Rev. 2006;3:CD005365.
15. Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, et al. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg. 2005;103:131-6.
16. Sciubba DM, Lin L, Woodworth GF, McGirth MJ, Carson B, Jallo GI. Factors contributing the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus [revista electrónica] 2007;22: E9.
17. Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003;98:725-30.
18. Davis SE, Levy ML, McComb JG, Masri-Lavine L. Does age or other factors influence the incidence of ventriculoperitoneal shunt infections? Pediatr Neurosurg. 1999;30:253-7.
19. Park P, Garton HJL, Kocan MJ, Thompson BG. Risk of infection with prolonged ventricular catheterization. Neurosurgery. 2004;55:594-601.
20. Rodríguez Guardado A, Maradona Hidalgo JA, Pérez González F, Cartón Sánchez JA, Blanco A, Rial JC, et al. Estudio comparativo de la meningitis posquirúrgica por Staphylococcus aureus sensible y resistente a meticilina. Med Clin (Barc). 2005;124:102-3.
21. Bayston R, Grove N, Siegel J, Lawellin D, Barsham S. Prevention of hydrocephalus shunt catheter colonization in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry. 1989;52:605-9.
22. Hampl J, Schierholz J, Jansen B, Aschoff A. In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien). 1995;133:147-52.
23. Kohnen W, Schaper J, Klein O, Tieke B, Jansen B. A silicone ventricular catheter coated with a combination of rifampin and trimethoprim for the prevention of catheter-related infections. Zentralbl Bakteriol. 1998;287:147-56.
24. Kohnen W, Kolbenschlag C, Teske-Keiser S, Jansen B. Development of a long-lasting ventricular catheter impregnated with a combination of antibiotics. Biomaterials. 2003;24:4865-9.
25. Schierholz JM, Pulverer G. Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination. Zentralbl Bakteriol. 1997;286:107-23.